咳喘宁对病毒诱发哮喘模型大鼠STAT6蛋白及其mRNA表达的影响
|
摘要
目的：本文运用分子生物学、显微形态学、免疫学、病毒学等实验技术,研究咳喘宁口服液对呼吸道合胞病毒诱发哮喘模型大鼠STAT6蛋白及其mRNA的表达的影响,为进一步阐明咳喘宁防治病毒诱发儿童哮喘的作用机理提供依据。
方法：①建立卵白蛋白哮喘大鼠模型并以呼吸道合胞病毒激发哮喘；②取支气管肺泡灌洗液(BALF)作细胞分类计数及比较BALF中IL-4与IL-12水平；分析IL-4、IL-12与STAT6蛋白和STAT6mRNA的相关性。采用免疫组织化学法和原位杂交法分别检测哮喘模型大鼠支气管中STAT6蛋白和STAT6mRNA的表达；③造模完成当天,常规分离PBS对照组、模型组各10只动物外周血单个核细胞,磁珠结合法分离CD4+T、CD8+T细胞,分别进行CD4+T、CD8+T细胞纯度鉴定与细胞活力检测,采用免疫荧光法,根据藻红蛋白(PE)荧光标记的抗体被激发出的荧光量多少,使用流式细胞仪确定T细胞内STAT6蛋白的表达水平,以中药咳喘宁进行干预,动态观察细胞培养过程中,咳喘宁对CD4+T、CD8+T细胞中STAT6蛋白表达的影响。
结果：与单纯OVA致敏哮喘大鼠模型比较,呼吸道合胞病毒(RSV)诱导OVA致敏的哮喘模型大鼠喘息症状重,气道反应性明显升高,气道粘膜下炎症细胞浸润明显加重。呼吸道合胞病毒诱发哮喘模型大鼠BALF显示模型组、地塞米松和沙丁胺醇组、咳喘宁治疗组的BALF细胞总数及分类计数均升高,尤其以嗜酸性粒细胞升高为主,与PBS对照组比较,差异有显著性意义(P<0.01)咳喘宁治疗组、地沙治疗组细胞总数明显低于模型组,差异有显著性意义(P<0.01)；咳喘宁治疗组细胞总数稍高于地、沙治疗组,但差异无显著性意义(P>0.05)。与PBS对照组比较,模型组BALF中IL-4水平显著增高而IL-12水平显著降低(P<0.01)。咳喘宁治疗后IL-4水平与模型组比较显著下降(P<0.01),与PBS对照组之间比较差异无统计学意义(P>0.05)；IL-12水平与模型组比较显著增高(P<0.01)。地、沙组与咳喘宁治疗组IL-4、IL-12比较差异无统计学意义(P>0.05)。通过IL-4、IL-12与STAT6蛋白及其1mRNA的相关性分析,IL-4与STAT6蛋白和STAT6mRNA呈正相关(r值分别为0.941,0.703,P<0.01);IL-12与STAT6蛋白和STAT6mRNA呈负相关(r值分别为-0.906,-0.866,P<0.01)。免疫组化法和原位杂交法检测,哮喘模型大鼠支气管中STAT6蛋白和STAT6mRNA的表达均较PBS组增高(P<0.01),经咳喘宁治疗后,模型大鼠肺组织炎症程度明显减轻,支气管STAT6及其mRNA较模型组表达明显减弱(P<0.0J1)。呼吸道合胞病毒诱发哮喘模型大鼠CD4+T较PBS组增高明显(P<0.01)、CD8+T含量增高不显著(P>0.05),模型组CD4+T、CD8+T内STAT6的表达水平显著高于地沙组和咳喘宁治疗组(P<0.01),经咳喘宁治疗后CD4+T、CD8+T内STAT6的表达显著降低(P<0.01)。
结论：咳喘宁能通过抑制病毒诱发哮喘模型大鼠支气管中STAT6及其mRNA的过度表达,下调CD4+T、CD8+T细胞内STAT6的表达,从而抑制BALF中IL-4的表达,纠正哮喘中Th2细胞的过度增殖分化,影响Th2免疫应答优势,并减少哮喘气道EOS的浸润,减轻模型大鼠气道炎症,降低其气道反应性,发挥防治病毒诱发哮喘的作用。
This article demonstrated the mechanism of kechuanning decoction on the rat model of asthma induced by RSV with experimental techniques such as molecular biology、Organization immunology and virology. The results were as follows:
Objective:To Study Kechuanning Decoction on Signal Transducer and Activator of Transcription6(STAT6) and its Gene Expression in the Rat Model of Asthma Induced by RSV.
Methods:The asthmatic model was established by OVA-sensitization of intraperitoneal injection and repeated inhalation of OVA combination of several times of intranasal inoculation with RSV (1.010O6PFU/ml in50ul).Asthma Symptoms were observed. The change of airway responsiveness (represented by lung resistance RL) and function of lung (represented by PEF and the ratio of FEV0.4/FVC) were determined. Lung tissue sections were stained with Hematoxylin and eosin (H&E) for general morphology. Sixty young male SD rats were randomly divided into four groups:PBS control group with twenty rats; asthma model group with twenty rats; group treated with Dexamethasone and Salbutamol with ten rats and group treated with kechuanning decoction with ten rats respectively. In the experiment, the rat asthma model was established by the ovalbumin (OVA) challenge methods and stimulated with Respiratory syncytial virus.The protein expressions of STAT6were detected by immunohistochemistry techniques; the mRNA expressions of STAT6were detected by hybridization in situ. Cells in bronchoalvoelar lavage fluid (BALF) were counted and classified. And the supernatants of the BALF were used of detection of IL-4、IL-12. The correlation analysis of IL-4、IL-12and STAT6protein and its mRNA were compared. When the model was finished, isolated the PBMC from the peripheral blood, separated CD4+T、CD8+T lymphocyte with immunomagnetic beads. The purity and activity of CD4+T and CD8+T were measured by using flow cytometry trypan-blue dye exclusion test,etc.The protein expression of STAT6were detected by fluorescence-activated cell sorting.
Results:Asthma symptoms were more severe in OVA/RSV group, compared with that of OVA group. RL increased and PEF、ratio of FEV0.4/FVC decreased in OVA/RSV group compared with those of OVA group (P<0.01).The bronchoconstriction and more inflammatory cells infiltration surrounding bronchi in the OVA/RSV group were found. Marked and extensive airway goblet cell hyperplasia and mucus retention in airway lumen in the OVA/RSV group were also observed. Immunohistochemistry and in situ hybridization showed that the expression of the protein content of STAT6and its mRNA around the bronchus of asthma group was significantly higher than that of the control PBS group and the treated group with kechuanning decoction and with Dexamethasone and Salbutamol (P<0.01), the epithelial cells were the chief expression cells; the expression of the protein content of STAT6and its mRNA of the treated group with kechuanning decoction was lower than the model asthma group (P<0.01) while a little higher than that of the treated group with Dexamethasone and Salbutamol, but it was no significance in statitics (P>0.05).Total BALF cells and more eosinophils in BALF from OVA/RSV group and the treated group with kechuanning decoction and with Dexamethasone and Salbutamol than those in PBS group were found (P<0.01). Total BALF cells were decreased in BALF from the treated group with kechuanning decoction and with Dexamethasone and Salbutamol than those in the asthma model group (P<0.01), but there were no differences in statistics between the treated group with kechuanning decoction and with Dexamethasone and Salbutamol. IL-4levels in BALF from the asthma model group increased greatly compared with the PBS group while IL-12levels were decreased (P<0.01), however IL-4levels in BALF from the treated group with kechuanning decoction decreased, compared with the PBS group, there were no significances in statistics (P>0.05)meanwhile the IL-12levels from the treated group with kechuanning decoction were increased compared with the asthma model group (P<0.01).There were positive correlation between IL-4、IL-12levels and the protein and the mRNA of STAT6(r=0.941,0.703respectively P<0.01),however negative correlation between IL-4、IL-12levels and the protein and the mRNA of STAT6(r=-0.906,-0.866respectively, P<0.01).The expression of the protein and the mRNA of STAT6were increased in the asthma model group, but it decreased in the treated group with kechuanning decoction. CD4+T lymphocyte in the asthma model group were increased however the hypertention of CD8+T lymphocyte were not significant (P>0.05),the expression of the protein of STAT6in the treated group with kechuanning decoction were decreased than it in the asthma model group (P<0.01)
Conclusions:Kechuanning decoction could decrease the expression of the protein and the mRNA of STAT6in the bronchus and decrease the expression of the protein of STAT6in CD4+T、CD8+T lymphocyte, thereby it could regulate the disorder of Th1/Th2, it aimed to control the asthmatic attack.
方法：①建立卵白蛋白哮喘大鼠模型并以呼吸道合胞病毒激发哮喘；②取支气管肺泡灌洗液(BALF)作细胞分类计数及比较BALF中IL-4与IL-12水平；分析IL-4、IL-12与STAT6蛋白和STAT6mRNA的相关性。采用免疫组织化学法和原位杂交法分别检测哮喘模型大鼠支气管中STAT6蛋白和STAT6mRNA的表达；③造模完成当天,常规分离PBS对照组、模型组各10只动物外周血单个核细胞,磁珠结合法分离CD4+T、CD8+T细胞,分别进行CD4+T、CD8+T细胞纯度鉴定与细胞活力检测,采用免疫荧光法,根据藻红蛋白(PE)荧光标记的抗体被激发出的荧光量多少,使用流式细胞仪确定T细胞内STAT6蛋白的表达水平,以中药咳喘宁进行干预,动态观察细胞培养过程中,咳喘宁对CD4+T、CD8+T细胞中STAT6蛋白表达的影响。
结果：与单纯OVA致敏哮喘大鼠模型比较,呼吸道合胞病毒(RSV)诱导OVA致敏的哮喘模型大鼠喘息症状重,气道反应性明显升高,气道粘膜下炎症细胞浸润明显加重。呼吸道合胞病毒诱发哮喘模型大鼠BALF显示模型组、地塞米松和沙丁胺醇组、咳喘宁治疗组的BALF细胞总数及分类计数均升高,尤其以嗜酸性粒细胞升高为主,与PBS对照组比较,差异有显著性意义(P<0.01)咳喘宁治疗组、地沙治疗组细胞总数明显低于模型组,差异有显著性意义(P<0.01)；咳喘宁治疗组细胞总数稍高于地、沙治疗组,但差异无显著性意义(P>0.05)。与PBS对照组比较,模型组BALF中IL-4水平显著增高而IL-12水平显著降低(P<0.01)。咳喘宁治疗后IL-4水平与模型组比较显著下降(P<0.01),与PBS对照组之间比较差异无统计学意义(P>0.05)；IL-12水平与模型组比较显著增高(P<0.01)。地、沙组与咳喘宁治疗组IL-4、IL-12比较差异无统计学意义(P>0.05)。通过IL-4、IL-12与STAT6蛋白及其1mRNA的相关性分析,IL-4与STAT6蛋白和STAT6mRNA呈正相关(r值分别为0.941,0.703,P<0.01);IL-12与STAT6蛋白和STAT6mRNA呈负相关(r值分别为-0.906,-0.866,P<0.01)。免疫组化法和原位杂交法检测,哮喘模型大鼠支气管中STAT6蛋白和STAT6mRNA的表达均较PBS组增高(P<0.01),经咳喘宁治疗后,模型大鼠肺组织炎症程度明显减轻,支气管STAT6及其mRNA较模型组表达明显减弱(P<0.0J1)。呼吸道合胞病毒诱发哮喘模型大鼠CD4+T较PBS组增高明显(P<0.01)、CD8+T含量增高不显著(P>0.05),模型组CD4+T、CD8+T内STAT6的表达水平显著高于地沙组和咳喘宁治疗组(P<0.01),经咳喘宁治疗后CD4+T、CD8+T内STAT6的表达显著降低(P<0.01)。
结论：咳喘宁能通过抑制病毒诱发哮喘模型大鼠支气管中STAT6及其mRNA的过度表达,下调CD4+T、CD8+T细胞内STAT6的表达,从而抑制BALF中IL-4的表达,纠正哮喘中Th2细胞的过度增殖分化,影响Th2免疫应答优势,并减少哮喘气道EOS的浸润,减轻模型大鼠气道炎症,降低其气道反应性,发挥防治病毒诱发哮喘的作用。
This article demonstrated the mechanism of kechuanning decoction on the rat model of asthma induced by RSV with experimental techniques such as molecular biology、Organization immunology and virology. The results were as follows:
Objective:To Study Kechuanning Decoction on Signal Transducer and Activator of Transcription6(STAT6) and its Gene Expression in the Rat Model of Asthma Induced by RSV.
Methods:The asthmatic model was established by OVA-sensitization of intraperitoneal injection and repeated inhalation of OVA combination of several times of intranasal inoculation with RSV (1.010O6PFU/ml in50ul).Asthma Symptoms were observed. The change of airway responsiveness (represented by lung resistance RL) and function of lung (represented by PEF and the ratio of FEV0.4/FVC) were determined. Lung tissue sections were stained with Hematoxylin and eosin (H&E) for general morphology. Sixty young male SD rats were randomly divided into four groups:PBS control group with twenty rats; asthma model group with twenty rats; group treated with Dexamethasone and Salbutamol with ten rats and group treated with kechuanning decoction with ten rats respectively. In the experiment, the rat asthma model was established by the ovalbumin (OVA) challenge methods and stimulated with Respiratory syncytial virus.The protein expressions of STAT6were detected by immunohistochemistry techniques; the mRNA expressions of STAT6were detected by hybridization in situ. Cells in bronchoalvoelar lavage fluid (BALF) were counted and classified. And the supernatants of the BALF were used of detection of IL-4、IL-12. The correlation analysis of IL-4、IL-12and STAT6protein and its mRNA were compared. When the model was finished, isolated the PBMC from the peripheral blood, separated CD4+T、CD8+T lymphocyte with immunomagnetic beads. The purity and activity of CD4+T and CD8+T were measured by using flow cytometry trypan-blue dye exclusion test,etc.The protein expression of STAT6were detected by fluorescence-activated cell sorting.
Results:Asthma symptoms were more severe in OVA/RSV group, compared with that of OVA group. RL increased and PEF、ratio of FEV0.4/FVC decreased in OVA/RSV group compared with those of OVA group (P<0.01).The bronchoconstriction and more inflammatory cells infiltration surrounding bronchi in the OVA/RSV group were found. Marked and extensive airway goblet cell hyperplasia and mucus retention in airway lumen in the OVA/RSV group were also observed. Immunohistochemistry and in situ hybridization showed that the expression of the protein content of STAT6and its mRNA around the bronchus of asthma group was significantly higher than that of the control PBS group and the treated group with kechuanning decoction and with Dexamethasone and Salbutamol (P<0.01), the epithelial cells were the chief expression cells; the expression of the protein content of STAT6and its mRNA of the treated group with kechuanning decoction was lower than the model asthma group (P<0.01) while a little higher than that of the treated group with Dexamethasone and Salbutamol, but it was no significance in statitics (P>0.05).Total BALF cells and more eosinophils in BALF from OVA/RSV group and the treated group with kechuanning decoction and with Dexamethasone and Salbutamol than those in PBS group were found (P<0.01). Total BALF cells were decreased in BALF from the treated group with kechuanning decoction and with Dexamethasone and Salbutamol than those in the asthma model group (P<0.01), but there were no differences in statistics between the treated group with kechuanning decoction and with Dexamethasone and Salbutamol. IL-4levels in BALF from the asthma model group increased greatly compared with the PBS group while IL-12levels were decreased (P<0.01), however IL-4levels in BALF from the treated group with kechuanning decoction decreased, compared with the PBS group, there were no significances in statistics (P>0.05)meanwhile the IL-12levels from the treated group with kechuanning decoction were increased compared with the asthma model group (P<0.01).There were positive correlation between IL-4、IL-12levels and the protein and the mRNA of STAT6(r=0.941,0.703respectively P<0.01),however negative correlation between IL-4、IL-12levels and the protein and the mRNA of STAT6(r=-0.906,-0.866respectively, P<0.01).The expression of the protein and the mRNA of STAT6were increased in the asthma model group, but it decreased in the treated group with kechuanning decoction. CD4+T lymphocyte in the asthma model group were increased however the hypertention of CD8+T lymphocyte were not significant (P>0.05),the expression of the protein of STAT6in the treated group with kechuanning decoction were decreased than it in the asthma model group (P<0.01)
Conclusions:Kechuanning decoction could decrease the expression of the protein and the mRNA of STAT6in the bronchus and decrease the expression of the protein of STAT6in CD4+T、CD8+T lymphocyte, thereby it could regulate the disorder of Th1/Th2, it aimed to control the asthmatic attack.
引文
[1]National Association of pediatric asthma Collaborative Group.The survey of children bronchial asthma prevalence between 1990 and 2000[J].Chinese Journal of tuberculosis and respiratory,2004,27(2):112-115.
[2]J Openshaw PJ.YamaguchiY,Tregoning JS.Childhood infections, the developing immune system and the origins of asthma[J].Allergy Clin Immunol,2004,114(6):1275-1277.
[3]Zheng J S,Zhu C,Su M S,Li C C,Jin X H, Chen X F.The etiological analysis of respiratory tract viral when acute asthma attacked of the following children under 5 years old[J]Journal of Wenzhou Medical College,2005,35(6):483-484.
[4]Dou L Y.Virus infection and exacerbation of acute asthma. Medical Journal of Western China.2007;22(]):193-194.
[5]Folkerts G,Nijkamp FP. Virus induced airway hyperresponsiveness:role of inflammatory cells and mediators. Am J Respir Crit Care Med,1995,151:1666-1674.
[ 6]Barnett K, Jacoby DB, Nadel JA, et al. The effects of epithelial cell supernatant on contractions of isolated canine tracheal smooth muscle.Am Rev Respir Dis,1988,138:780-783.
[7]杨季国,徐朝晖.呼吸道合胞病毒与哮喘关系的研究[J].浙江中医学院学报,2005,29(6)：97-99.
[8]欧立文,张平.IL-12/IL-4失衡与支气管哮喘[J].美国中华临床医学杂志,2003,5(4)：330-332.
[9]史菲,邱晨.肺表面活性物质对哮喘发作期T细胞活化表达CD69的影响.中华结核和呼吸杂志.2004,27(5)：353-354.
[10]Curt MH. STAT proteins and transcriptional response to extracellular signals. TISs,2000,25:496-502.
[11]Moitreyee CK,Follo VDA,George RS.Association of STATs with relatives and friends.Trend Cell Biology.2000,10:106-111.
[12]Kaplan MH.Grusby M J.Regulation of T helper cell differentiation by STAT molecules[J].Leukoc Biol,1998,64:2-5.
(13)Noble A,Thomas MJ, Kemeny DM. Early Thl/Th2 cell polarization in the absence of IL-4 and IL-12:T cell receptor signaling regulates the response to cytokines in CD4+ T and CD8+ T cells. Eur J Immunol. 2001,31(7):2227-2230.
[14]Hoshino A,Tsuji T,Matsuzaki J,Jinushi T.Ashino S.Teramura T,Chamoto K,Tanaka Y Asakura Y, Sakurai T, MitaY Takaoka A, Nakaike S, Takeshima T, Ikeda H, Nishimura T. STAT6-mediated signaling in Th2-dependent allergic asthma:critical role for the development of eosinophilia,airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation. Int Immunol.2004,16(10):1497-1505.
(15)Schedel M,Carr D.Klopp N,Woitsch B,Illig T, Stachel D,Schmid I, Fritzsch C,Weiland SK, von Mutius E, Kabesch M. A signal transducer and activator of transcription 6 haplotype influences the regulation of serum IgE levels. J Allergy Clin Immunol.2004,114(5):1100-1105.
(16)Wang M Q,Luo Y H,Chen X J,Zhu Y,Liu K L,Mo F J,Shu L.The clinical study of the treatment of Kechuanning decoction on asthma induced by RSV[J].New traditional Chinese medicine, 2007,39(4):16-17.
(17)Zhu Y,Wang M Q,Luo Y H,Chen X J,Liu K L,Mo F J,Shu L.The clinical study and the analysis of related factors of the treatment of Kechuanning decoction on asthma induced by RSV[J].Chinese Journal of information on traditional Chinese Medicine.2007,14(2):63-64.
(18)Wang M Q,Luo Y H,Chen X J.Zhu Y.Liu K L,Mo F J.Shu L.The regulation on subgroup Th by Kechuanning decoction on asthma induced by RSV[J].Chinese Journal of traditional Chinese Medicine,2007,22(7):481-483.
[19]Dong X F,Luo Y H,Wang M Q,Chen X J, Zhu Y.The regulation of EOS on asthmatic guinea pig by Kechuanning decoction[J]. Journal of Hunan University of traditional Chinese Medicine, 2008,28(5):36-37,60
[1]Teichtahl H.Buckmaster N.Pertnikovs E.The incidence of respiratory tract infection in adults requiring hospitalization for asthma. Chest,1997.112:591-596.
[2]Zheng J S,Zhu C.Su M S,Li C C,Jin X H,Chen X F.The etiological analysis of respiratory tract viral when acute asthma attacked of the following children under 5 years old[J]Journal of Wenzhou Medical College,2005,35(6):483-484.
[3]Cui FF.Xin D L. Animal model of bronchial asthma[J]. Laboratory animal and comparative medicine.2009.29(4):277-281
[4]Xiao C J.Research on the mechanism of clearing the lung and antiasthmatic method and syndrome differentiation of Pediatric Heat-asthma microcosmic.[J]Doctoral Dissertation of Hunan University of Chinese Medicine.2001,25-38.
[5]Liu L N.Yang J G,Cheng D Q.Buiding of asthma mice model induced by Respiratory syncytial virus [J] Journal of Zhejiang University of traditional Chinese Medicine.2007.31(2):154-155.157.
[6]Jiang H L,Li Y P.Zhou T Y. changes of T lymphocyte subsets in airway of Asthma mice [J].The Journal of Practical Medicine,1999,15(7):585-586.
[7]Ji L L.Xu L,Shi L,Feng L. The research of the evaluation and the observation on asthma animal model [J]. Chinese Journal of Comparative Medicine.2009,19(1):72-75.
[8]徐立,范欣生,何胜旭.复方辛夷口服液对卵蛋白致敏豚鼠支气管哮喘的影响[J]南京中医药大学学报.2004,20(2)：104-106.
[9]蒋雄斌,朱毅,殷凯生.重度哮喘小鼠模型的建立[J]中国危重病急救医学.2006.18(12)：733-737.
[10]徐叔云.卞如濂,陈修.药理实验方法学(第2版)[M].北京：人民卫生出版社,1991：1171-1195.
[11]Katsunori K.Bosken CH, Pare PD.et al. Small airways dimensions in asthma and chronic obstructive pulmonary disease [J].Am Rev Respir Dis,1993,148:1220-1225.
[12]董泽华,魏剑琴,黄瑾,等.哮喘豚鼠模型痉挛气道的解痉挛规律[J]吉林大学学报.2006,32(4)：562-563.
[13]毕玉田，王彦,吴奎等.屋尘螨致敏激发小鼠气道变态反应性炎症模型的构建[J].中国实验动物学报，2007,15(5)：338-340.
[14]胡作为,周电光,周燕萍,等.中药止哮平喘方抗哮喘豚鼠模型气道炎症的实验研究[J].广州中医药大学学报.2004,21(1)：40-42.
[15]赖克方,王长征,郭先健,等.支气管哮喘豚鼠肺内嗜酸粒细胞增多和凋亡的关系[J].广东医学.2001,22[2]98-99.
[16]陈奇.中药药理研究方法学(第2版)[M].北京：人民卫生出版社,2006：642-643.
[17]张全爱.哮喘模型豚鼠变态反应机制的实验研究[J].甘肃中医学院,2003.20(4)：16-17.
[18]陈莹,戴晋.多种细胞因子在哮喘大鼠发病中的作用[J].中国组纽织工程研究与临床康复.2007,11(27)：5324-5327.
[19]Matthiesen S. Bahulayan A, Holz O,et al.MAPK pathway mediates muscarinic receptor-induced human lung fibroblast proliferation[J]Life Sci.2007(24-25):2259-2262.
[20]Liu S Z.LiuY L.Cao G L, et al.The points of immune inflammation verification in Animal models of asthma [J] Chinese Journal of clinical rehabilitation,2007,11(22):5814-5816.
[21]Chin J. Magoffin RL, Shearer LA, et al. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol 1969:89 (4):449-463.
[22]张惠兰.张珍祥,徐永健,等.用紫外线灭活的呼吸道合胞病毒复制小鼠哮喘动物模型.中国病理生理杂志.2002.18：1561-1563.
[23]沈华浩.三苹莉.支气管哮喘小鼠模型应用评价.中华结核和呼吸杂志.2005：28：284-286.
[24]Makela MJ. Tripp R. Dakhama A, et al. Prior aiway exposure to allergen increases virus-inudced airway hyperresponsiveness. J Allegry Clin Immunol,2003.112:61-69.
[1]Dou L Y.Virus infection and exacerbation of acute asthma.Medical Journal of Western China.2007; 22(1):193-194.
[2]BARNES P J.ADCOCK I M.Transcription factors and asthma[J].Eur Respir J,1998.12(1):221-234.
[3]LICC,YEL,CHEN X F. et al.Expression of signal transducer and activator of transcription 6 in rat asthma model and the modulatory effect of dexamethasone[J].Chin J Pediatr(中华儿科杂志),2005,43(7):521-525.
[4]Chinese Medical Association of pediatric subspecialty group of respiratory.The routine of prevention and treatment of bronchial asthma of children (on trial)[J].Chinese Journal of Pediatrics,2004,42:100-106.
[5]Barnes PJ, Adeock IM. Transcription factors and asthma [J].EUr Respir J.1998,12:221-234.
[6]Huang W L.Zhu X F. Signal transduction.BeiJing:People hygiene press,2005.
[7]Kaphlan MH.Nyce JW,Metager WJ,et al.DNA antisense therapy for asthma in an animal model.[J]Immunol Baltimore,1998,160(4):1850-1856.
[8]Wang M Q,Luo Y H,Chen X J.Zhu Y,Liu K L.Mo F J,Shu L.The regulation on Th subgroup by Kechuanning decoction on asthma induced by RSV[J].Chinese Journal of traditional Chinese Medicine, 2007,22(7):481-483.
[9]Kuo CT Leiden JM.Transcriptional regulation of T lymphocyte development and function.[J].Annu Rev Imnunol,1999.17:149-187.
[10]Steinke JW, Borish L. Th2 cytokines and asthma.Interleukin-4:its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists[J].Respir Res.2001;2(2):66-70. Epub 2001 Feb 19.
[11]Gately MK.Renzetti LM.Magram J.et al.The IL-12/IL-12R system:role in normal and pathologic immune responses.[J].Annu Rev Immunol.1998.16:495-521.
[12]Teichtahl H.Buckmaster N.Pertnikovs E.The incidence of respiratory tract infection in adults requiring hospitalization for asthma[J].Chest,1997.112:591,496.
[13]Ye L P,Xie L W,Li C C,Wu S Z.Li M R.The expression of signal transducer and activator of transcription 6 in asthmatic rats by Budesonide[J]Chinese Journal of Microbiology andImmunology,2005,25(7):588-593.
[14]Kaplan MH.Grusby M J.Regulation of T helper cell differentiation by STAT molecules[J].Leukoc Biol,1998,64:2-5.
[15]Wang M Q.Luo Y H.Chen X J,Zhu Y.Liu K L,Mo F J,Shu L.The clinical study of the treatment of Kechuanning decoction on asthma induced by RSV[J].New traditional Chinese medicine,2007,39(4):16-17.
[16]Zhu Y.Wang M Q,Luo Y H,Chen X J.Liu K L.Mo F J,Shu L.The clinical study and the analysis of related factors of the treatment of Kechuanning decoction on asthma induced by RSV[J].Chinese Journal of information on traditional Chinese Medicine,2007,14(2):63-64.
[17]Wang M Q,Luo Y H,Chen X J,Zhu Y,Liu K L.Mo F J.Shu L.The regulation on Th subgroup by Kechuanning decoction on asthma induced by RSV.[J].Chinese Journal of traditional Chinese Medicine.2007,22(7):481-483.
[18]Dong X F.Luo Y H,Wang M Q,Chen X J,Zhu Y,The regulation of EOS on asthmatic guinea pig by Kechuanning decoction[J].Journal of Hunan University of traditional Chinese Medicine,2008,28(5):36-37,60
[1]Cho SH.Stanciu LA,Begishivili T,Bates PJ.Holgate ST, Johnston SL.Peripheral blood CD4- and CD8 T cell type 1 and type 2 cytokine production in atopic asthmatic and normal subjects[J].Clin Exp Allergy. 2002.32(3):427-33.
[2]Miyahara N.Takeda K.Kodama T,Joetham A.Taube C.Park JW.Miyahara S.Balhorn A,Dakhama A.Gelfand EW.Contribution of antigen primed CD8+ T cells to the development of airway hyperresponsiveness and inflammation is associated with IL-13[J].Immunol.2004.172(4):2549-58.
[3]Niedbala W,Wei X.Liew FY. IL-15 induces type 1 and type 2 CD4+ and CD8- T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12/IL-4 stimulation in vitro[J].Eur J Immunol,2002,32(2):341-7.
[4]Cherwinski HM,Schumacher JH.Brown KD et al.Two types of mouse helper T cell clone.III.Further differences in lymphokine synthesis between Thl and Th2 clones revealed by RNA hybridization functionally monospecific bioassays.and monoclonal antibodies[J].Exp Med.1987;166:1229-1244
[5]Ransom J,Fischer M.Mosmann T.et al.Interferon-gammal is produced by activated immature mouse thymocytes and inhibits the interleukin 4-induced proliferation of immature thymocytes[J]. Immunol,1987:139:4102-4.108
[6]Fiorentino DF.Bond MW.Mosmann TR.Two types of moues T helper cell. IV Th2 clones secrete a factor that inhibits cytokine production by Thl clones[J].Exp Med.1989:170:2081-2095
[7]Fernandez-Botran R.Sanders VM.Mosmann TR et al.Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells[J].Exp Med 1988; 168:543-558
[8]Sher A.Gazzinelli RT.Oswald IP,et al. Role of T-Cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection[J].Immunol Rev.1992; 127:183-204
[9]Katsunuma T,Kawa hara H.Suda T,Ishii T,Ohya Y,Akasawa A,Saito H,Oshida T,Sugita Y.Analysis of gene expressions of T cells from children with acute exacerbations of asthma[J].Int Arch Allergy Immunol.2004,134(1):29-33.
[10]Noma T,Sugawara Y.Aoki K.Kawa no Y,Ishikawa Y,Matsuura N.Induction of peripheral mononuclear cell apoptosis in asthmatic patients in remission[J].Asthma.2002.39(7):591-601.
[11]Bach FH.Delayed xenograft rejection[J].Immunology Today,1996,11:63-67.
[12]MosmannTR.Cytokines:is there biological meaning?[J].Curr OPin Immunol.1991 Jun;3(3):311-4.
[13]Shiota Y, Arikita H, Horita N, Hiyama J, Ono T, Yamakido M. Intracellular IL-5 and T-lymphocyte subsets in atopic and nonatopic bronchial asthma[J].Allergy Clin Immunol.2002.109(2):294-8.
[14]Cho SH,Stanciu LA.Holgate ST,Johnston SL.Increased interleukin-4,interleukin-5 and interferon-gamma in airway CD4-and CD8+T cells in atopic asthma.Am J Respir Crit Care Med.2005.171(3):224-30.
[15]Shi HZ,Sun JJ,Pan HL,LuJQ,Zhang JL,Jiang JD.Alternations of T-lymphocyte subsets,soluble IL-2 receptor.and IgE in peripheral blood of children with acute asthma attacks[J].Allergy Clin Immunol.1999.103(3pt1):388-394.
[16]Shi JH,Li TS.Lin YG.The evolvement of Thl/Th2 imbalance accommodates to the progress of airway inflammation in asthmatic subjects and rat model[J].Chinese Medical Journal.2004.84(17):1440-4.
[17]Lee SY,Kim SJ,Kwon SS,Kim YK.Kim KH.Moon HS.Song JS,Park SH. Distribution and cytokine production of CD4 and CD8'T-lymphocyte subsets in patients with acute asthma attacks[J].Ann Allergy Asthma Immunol.2001.86(6):659-64.
[18]Kelly-welch AE,Hanson EM,Boothby MR.Keegan AD.Interleukin-4 and Interleukin-13 signaling connections Maps[J].Science.2003.300(5625):1527-1528.
[19]Schedel M.Carr D.Klopp N.Woitsch B,l Ilig T,Stachel D.Schmid I.Fritzsch C.Weiland SK.Von Mutius E.Kabesch M.A signal transducer and activator of transcription 6 haplotype influences the regulation of serum IgE levels[J].Allergy Clin Immunol.2004.114(5):1100-5.
[20]Ammit AJ.Panettieri RA Jr.Invited review the circle of life:cell cycle regulation in airway smooth muscle[J].App] physiol.2001,91 (3):1431-7.
[21]Shi H Z,Lin J T.Immunology of lung and immune related diseases[M].BeiJing:People hygiene press,2006:316-317.
[22]Sheng Q,He J Y,Zhou A L,et al.The expression of signal transducer and activator of transcription 6 and Eotaxin by Triptolide on asthmatic mice[J].International Journal of Cardiology,2006,26(1):12-15.
[23]Wang M Q,Luo Y H.Chen X J.Zhu Y,Liu K L,Mo F J,Shu L.The regulation on subgroup Th by Kechuanning decoction on asthma induced by RSV[J].Chinese Journal of traditional Chinese Medicine,2007,22(7):481-483.
[24]Dong X F.Luo Y H.Wang M Q,Chen X J.Zhu Y.The regulation of EOS on asthmatic guinea pig by Kechuanning decoction[J].Journal of Hunan University of traditional Chinese Medicine.2008.28(5):36-37,60.
[1]汪受传主编.中医儿科学[M].北京：中国中医药出版社,2002.75
[2]郭云霞.儿童哮喘证治的中医药研究摘要[J].中医药学刊，2002,20(2)：201
[3]洪广祥.哮证治疗之我见[J].中医杂志,1998，29(3)：7
[4]王根军.从风痰论治急性发作期支气管哮喘[J].中华实用中西医杂志,2005,18(13)：233
[5]沈自尹.补肾法预防哮喘的变态和非变态反应机制研究[J].中西医结合杂志,1989，9(2)：82
[6]史锁芳.哮喘“夙根”探讨[J].中医药学报,1994,(3)：6
[7]韦衮政.敖素华.胡天成治疗小儿哮喘经验举隅[J].辽宁中医杂志.2002.29(10)：585
[8]彭红星.陈陶后教授治疗小儿哮喘经验[J].山西中医,1995,(2)：5
[9]张伟.邵雨萌.再论哮喘从瘀论治[J].湖南中医学院学报.2004.24(3)：24
[10]朱鹏.复元活血汤治疗哮喘12例疗效观察[J].江西中医药,1995,(5)：33
[11]廖世才.小儿哮喘活血化瘀法治疗体会[J].江西中医药.1997,28(6)：33
[12]洪霞,廖宝军.从痰瘀论治小儿哮喘116例分析.陕西中医函授.2000.(5)：41
[13]周仲瑛.哮喘杂谈.江苏中医.2000.21(18)：15
[14]洪广祥.哮证治疗之我见[J].中医杂志.1988,29(3)：7
[15]胡国俊.胡翘武治疗支气管哮喘的经验[J].中国医药学报.1993.8(5)：56
[16]张建明.哮喘有因血虚论[J].中医杂志.1992,33(9)：57
[17]沈俊元.中西医结合治疗小儿支气管哮喘36例[J].中国中西医结合杂志，1995,15(12)：754
[18]高淑英.哮喘从肝肺论治探讨[J].中国中医药信息杂志,2006,13(8)：77
[19]武维屏,崔红生.试论支气管哮喘从肝论治的生理病理学基础[J].中国中医基础医学杂志,2002,8(10)：7-8
[20]毛玉燕.钱育寿.治疗小儿哮喘的经验.河北中医，2000.22(3)：174
[21]王青海,黄琳.等.胃不和与支气管哮喘的关系初探[J].广东医学,2001,22(8)：755
[22]许建中.吴银根,李明华.中西医结合哮喘病学[M1.北京：人民卫生出版社.2001,7
[23]刘小凡,司东波.小儿哮喘间歇期的证治探讨[J].中国中医急症,2004,13(5)：29
[24]罗玉华.小儿哮喘的中医辨证治疗.四川中医.2002,20(1)：17
[25]曹宏,陈鲁.补肾培元法治疗小儿哮喘体会[J].陕西中医，2000.21(8)：3
[26]范钰,万救钢,万铭.等.黄芪注射液对哮喘患者气道反应性的影响[J].新中医,2001，33(4)：27
[27]王孟清.朱哗,舒兰,等.截哮口服液防治病毒诱发小儿哮喘的临床研究[J].中国中西医结合杂志,2003.23(12)：902-904
[28]周志荣.复方太子参止咳益气散治疗支气管哮喘2180例疗效观察.中国民族医药杂志,2005(5)：12
[29]杨明升.儿康宁佐治婴幼儿哮喘缓解期疗效观察[J].实用中西医结合杂志,1995,11(1)：52
[30]贺双腾.等.五虎汤对呼吸道卫国合胞病毒复制的抑制作用研究.[J]中草药.1995,26(11)：585.
[31]阎玉田，等.中西医结合治疗合胞病毒肺炎的临床,病理及发病机制研究.[J]中国中西医结合急救杂志.1999,6(11)：489.
[32]廖传胜，等.柴胡注射液抑制RSV的研究.[J]深圳中西医杂志.1999,9(2)：20.
[33]董艳梅,等.甘草体外抑制呼吸道合胞病毒作用的研究.[J]中药材.2004,27(6)：425-427.
[34]余栋华.鱼腥草注射液治疗小儿合胞病毒性肺炎41例.现代中西医结合杂志.1999,8(2)：1957.
[35]樊宏伟,等.苦参碱类生物碱的体外抑菌,抑病毒及诱生干扰素的实验研究.[J]中医药信息.2000,(4)：75.
[36]杨桦.人参多糖抗RSV感染的作用机制研究.[J]中国药理学通报.1997,13(4)：382.
[1]全国儿科哮喘协作组.2000年与1990年儿童支气管哮喘患病率的调查比较.中华结核和呼吸杂志，2004，27(2)：112-115.
[2]Openshaw PJ,YamaguchiY,Tregoning JS.Childhood infections,the developing immune system.and the origins of asthma[J]. Allergy Clin Immunol.2004.114(6):1275-1277.
[3]郑吉善，朱春.苏苗赏.李昌崇.金小红.陈小芳.5岁以下儿童哮喘急性发作时呼吸道病毒病原学检测分析.[J].温州医学院学报.2005.35(6)：483-484.
[4]窦丽阳.病毒感染与哮喘的急性加重.华西医学2007；22(1)：193-194.
[5]The global initiative for asthma. Global strategy for asthma management and prevention:mechanisms of asthma [M].New York:National institutes of health,2002:50-54.
[6]Kim CK,Kim SW,Park CS,etal. Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis[J].Allergy Clin Immunol.2003,112(1):64
[7]Brooks GD,Buchta KA..Swenson CA,et al.Rhingovirus-indueced interferon-γand airway responsiveness in asthma[J].Am J Respir Crit Care Med,2003,168(9):1091.
[8]Papadopoulos NG,Stanciu LA,Papi A.et al.A defective typelresponse to rhinovirus in atopic asthma[J].Thorax,2002,579(4):328.
[9]Legg JP,Hussain IR,Warner JA,et al. Typeland type2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis[J].Am J Respir Crit Care Med,2003,168(6):633
[10]Zambrano JC.Carper HT,Rakes GP,et al. Experimental rhinovirus challenges in adults with mild asthma: response to infection in relation to IgE[J].J Allergy Clin lmmunol,2003,111 (5):1008
[11]Yamaya M, Sasaki H. Rhinovirus and asthma [J].Viral Immunol.2003.16(2):99
[12]McNamara PS, Flanagan BF, Baldwin LM, et al. Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis [J].Lancet.2004,363(9414):1031
[13]Park JW, Taube C,Yang ES,et al. Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen[J].Allergy Clin Immunol,2003,112(6):1078
[14]Kong X, San Juan H, Kumar M,et al. Respiratory syncytial virus infection activates STAT signaling in human epithelial cells[J].Biochem Biophys Res Commun,2003,306(2):616
[15]Samransamruajkit R, Moonviriyakit K, Vanapongtipagorn P,et al. Plasma endothelin-1in infants and young children with acute bronchiolitis and viral pneumonia[J].Asian Pac J Allergy Immunol,2002.20(4):229
[16]Chauhan AJ. Inskip HM Linaker CH, et al. Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children[J]. Lancet,2003.361(9373):1939
[17]Oh JW, Lee HB, Park IK,et al.Interleukin-6. interleukin-8. interleukin-11, and interferon-gamma levels in nasopharyngeal aspirates from wheezing children with respiratory syncytial virus or influenza A virus infection[J].Pediatr Allergy Immunol.2002.13(5):350.
[18]薛辛东,李永柏.儿科学[M]北京：人民卫生出版社.2002.229-241.
[19]Empey DW, Laitinen LA.Jacobs L.et al.Mecanisms of bronchial hyperreactivity in normal subjects following upper respiratory tract infection[J].Amm Rev Respir Dis.1976,113(2):523.
[20]Folkerts G,Vanderlinde HJ,Nijkamp FP.Virus indueced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide[J].Clin Invest. 1995.95(1 ):26
[21]Fryer AD,Maclagan J.Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig[J].Br J Pharmacol, 1984.83(4):973
[22]Jacoby DB,Xiao HQ,Lee NH.et al.Virus and interferon induced los of inhibitory M2 muscarinic receptor function and gene expression in guinea-pig airway parasympathetic neurons[J].Clin Invest.1998, 102(1):242
[23]Costello RW, Schofield BH, Kephart GM, et al.Lolization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function[J].Am J Physiol. 1997.273( 1 ):93
[24]Adamko DJ. Fryer AD. Bochner BS,et al. CD8+ T lymphocytes in viral hyperreactivity and M2 muscarinic receptor dysfunction[J]. Am J Respir Crit Care Med. 2003.167(4):550
[25]鹿强.杨卫,杨永丰.支气管哮喘的气道重塑.[J]河北医药.2010.32(10)：1299-1301.
[26]Wilsion JW. Lack of airway distensibHty in asthma. AM. Rev, Respir. Dis.1993,148:806-809.
[27]Kraft M.Martin RJ.Wilson S,et al.Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med, 1999,159:228-234.
[28]Srivastava P. Helms PJ, Stewart D.et al. Association of CCR5D et al .32 with reduced risk of childhood but not adult asthma[J].Mol Biotechnol.2003.23(l):51-60.
[29]Yao TC, Kuo ML,See LC,et al. The RANTES promoter polymor-phism:a genetic risk factor for near-fatal asthma in Chinese children[J].Thorax.2003.58(6):466-469.
[30]Van EP,Little RD,Dipuis J,et al. Association of the ADAM-33 gene with asthma and bronchial hyperresponsiveness [J].Nature, 2002.418:426-430.
[31]Urban JF et al.J Immunol Baltimore, 2000, 164(4):2046-2052 .
[32]Kplan MH et al.J Immunol Baltimore. 1998. 160(4): 1850-1856.
[33]Stamm LM et al.J Immunol Baltimore, 1998. 161(11):6180-6188.
[34]Guell FW et al. Mol Cell Biol,1995. 15(6):3336-3343.
[35]Yokozeki H et al.J Exp Med.2000.191(7):995-l()04.
[1]蒋雄兵.朱毅，殷凯生,等.CD8mAb对呼吸道合胞病毒诱导的哮喘小鼠气道炎症的影响[J].第四军医大学学报.2006,27(12)：1086-1089.
[2]王孟清,罗银河.陈锡军.朱晔,刘克丽.莫非钧，舒兰.咳喘宁治疗病毒诱发的儿童哮喘的临床研究[J].新中医，2007.39(4)：16-]7.
[3]王孟清,罗银河,陈锡军,朱晔,刘克丽，莫非钧.舒兰.咳喘宁对病毒诱发哮喘患儿Th亚群的调节作用[J].中华中医药杂志,2007,22(7)：481-483.
[4]董晓斐,罗银河.王孟清.陈锡军.朱晔.咳喘宁对哮喘豚鼠EOS的调节作用[J].湖南中医药大学学报.2008.28(5)：36-37.
[5]杨季国,徐朝晖,等.平喘Ⅰ号对呼吸道合胞体病毒哮喘小鼠血清IL-4.IFN-γ的影响[J].中国中医药科技,2008.15(1)：26-27.
[6]蔡宛如,等.芍药甘草汤平喘和抗过敏的实验研究[J].中国中西医结合急救杂志.2000.11(6)：341-342.
[7]王力宁.等.六味地黄丸协同必可酮对致敏豚鼠气道反应性和血嗜酸细胸的影响[J].广西中医药.2000,2(6)：52-53.
[8]张建勇.火把花根片对哮喘豚鼠气道炎症的作用[J].贵州医药,2001，11(10)：89-92.
[9]薛汉荣,等.益气温阳护卫汤对缓解期哮喘患者气道反应性的影响及作用机理研究[J].中国医药学报.2004,19(8)：477.
[10]李彤.平哮合剂对哮喘气道高反应性的影响[J].山西中医.2001,17(3)：44.
[11]Fish JE,Peters SP.Airway remodeling and persistent airway obstruction in asthma[J].Allergy clin Immunol,1999,104 (3Pt1):509.
[12]吴银根,王丽新.基质金属蛋白酶及其抑制剂在哮喘气道重塑中的作用及止喘胶囊的干预[J].中西医结合学报,2004,2(6)：435.
[13]汪珊,梁仁.中药地龙药理与哮喘气道重建相关性研究[J].广东药学院学报,2004,20(1)：60.
[14]Hogansp,KoskinerA,MatthaeiK1,et al.Interleukin-5 producing CD4+T cell spalyapivotal roleinaero allegen-induced eosinophilia,bronchial hyperreactivity and lung damage immune Am[J].Respir Crit Care Med 1998,157(1):210-218.
[15]Mudle R,Chancz P,Campbell AM,et al.Different eytokine paterns in bronchial bisopsies in asthma and chronic bronchitis[J].respir Med,1996,90(2):79.
[16]张在其,梁仁,黄建明.小青龙汤对哮喘小鼠肺组织Thl/Th2作用的实验研究[J].中国中西医结合急救杂志,2004,(6)：368-370.
[17]张莉,孙建宁,周勇.等.芩夏止哮颗粒对豚鼠支气管平滑肌的影响及平喘作用[J].北京中医药大学学报.1999,11(6)：42-44.
[18]壮健,孙秀芳.徐教萍，等.消喘膏贴敷对哮喘豚鼠Thl/Th2类细胞因子的影响[J].四川中医.2003,1(6)：13.
[19]罗光伟，孙浩民，陈菁.射干麻黄汤对哮喘豚鼠气道ECP和嗜酸性粒细胞凋亡的影响[J].中国中医急症,2006,15(6)：639-640.
[20]方向明.曹世宏.平喘合剂对哮喘豚鼠T淋巴细胞凋亡的影响[.11.中国中医基础医学杂志,2003,9(3)：]84-186.
[21]王宏长.李培成，吴银根.中药咳喘落对实验性哮喘豚鼠ECP和sICAM-1的影响[J].广东医学,2000.21(3)：]88-190.
[22]李刚,柳春，李莉,等,复方抗敏灵对哮喘大鼠ICAM-1表达及PL A2的影响[J].微生物学杂志,2000,20(2)：39.
[23]魏庆宇，李刚.柳春.加味玉屏风散对哮喘大鼠支气管上皮ICAM-1的表达及BALF中IL-5含量的影响[J].中国实验方剂学杂志.2001.(5)：40-42.
[24]郑洁湖国信,邱忠民.蠲哮片对哮喘豚鼠sICAM-1蛋白水平及ICAM-1基因表达的影响[J].江西中医学院学报.2003,15(4)：42-44.
[25]林科雄,雷公藤对哮喘豚鼠GM-CSF基因转录的影响与作用机制[J].中国免疫学杂志,2000,(9）：325-327.
[26]李志奎,等.雷公藤甲素对哮喘豚鼠嗜酸性粒细胞凋亡及Fas、Bcl、MRNA表达的影响[J].中国新药与临床杂志,2002,5(5)：261-262.
[27]王宏长,等.中药哮喘落对哮喘大鼠肺组织白细胞介素-4、IL-5mRNA影响及相关性研究[J].广东医学.2000,21(2)：107.
[28]范欣生,等.复方辛夷平喘液对哮喘豚鼠肺内ICA及淋巴细胞fas表达的影响[J].中华结核和呼吸杂志,2002,25(5)：280.
[29]刘永刚,罗佳波.麻黄汤及拆方对哮喘小鼠5.脂质氧合酶激活蛋白、白介素4基因的表达和影响[J].中国中药杂志,2007.32(3)：246-248.
[30]方向明,王军.平喘宁对哮喘豚鼠肺组织中GM-CSF mRNA表达的影响[J].中华中医药杂志.2005.20(9)：538-541.
[31]张毅敏.穴位敷贴对哮喘豚鼠嗜酸性粒细胞凋亡及其调控基因的影响[J].北京中医药大学学报,2006,29(6)：393-395.
[2]J Openshaw PJ.YamaguchiY,Tregoning JS.Childhood infections, the developing immune system and the origins of asthma[J].Allergy Clin Immunol,2004,114(6):1275-1277.
[3]Zheng J S,Zhu C,Su M S,Li C C,Jin X H, Chen X F.The etiological analysis of respiratory tract viral when acute asthma attacked of the following children under 5 years old[J]Journal of Wenzhou Medical College,2005,35(6):483-484.
[4]Dou L Y.Virus infection and exacerbation of acute asthma. Medical Journal of Western China.2007;22(]):193-194.
[5]Folkerts G,Nijkamp FP. Virus induced airway hyperresponsiveness:role of inflammatory cells and mediators. Am J Respir Crit Care Med,1995,151:1666-1674.
[ 6]Barnett K, Jacoby DB, Nadel JA, et al. The effects of epithelial cell supernatant on contractions of isolated canine tracheal smooth muscle.Am Rev Respir Dis,1988,138:780-783.
[7]杨季国,徐朝晖.呼吸道合胞病毒与哮喘关系的研究[J].浙江中医学院学报,2005,29(6)：97-99.
[8]欧立文,张平.IL-12/IL-4失衡与支气管哮喘[J].美国中华临床医学杂志,2003,5(4)：330-332.
[9]史菲,邱晨.肺表面活性物质对哮喘发作期T细胞活化表达CD69的影响.中华结核和呼吸杂志.2004,27(5)：353-354.
[10]Curt MH. STAT proteins and transcriptional response to extracellular signals. TISs,2000,25:496-502.
[11]Moitreyee CK,Follo VDA,George RS.Association of STATs with relatives and friends.Trend Cell Biology.2000,10:106-111.
[12]Kaplan MH.Grusby M J.Regulation of T helper cell differentiation by STAT molecules[J].Leukoc Biol,1998,64:2-5.
(13)Noble A,Thomas MJ, Kemeny DM. Early Thl/Th2 cell polarization in the absence of IL-4 and IL-12:T cell receptor signaling regulates the response to cytokines in CD4+ T and CD8+ T cells. Eur J Immunol. 2001,31(7):2227-2230.
[14]Hoshino A,Tsuji T,Matsuzaki J,Jinushi T.Ashino S.Teramura T,Chamoto K,Tanaka Y Asakura Y, Sakurai T, MitaY Takaoka A, Nakaike S, Takeshima T, Ikeda H, Nishimura T. STAT6-mediated signaling in Th2-dependent allergic asthma:critical role for the development of eosinophilia,airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation. Int Immunol.2004,16(10):1497-1505.
(15)Schedel M,Carr D.Klopp N,Woitsch B,Illig T, Stachel D,Schmid I, Fritzsch C,Weiland SK, von Mutius E, Kabesch M. A signal transducer and activator of transcription 6 haplotype influences the regulation of serum IgE levels. J Allergy Clin Immunol.2004,114(5):1100-1105.
(16)Wang M Q,Luo Y H,Chen X J,Zhu Y,Liu K L,Mo F J,Shu L.The clinical study of the treatment of Kechuanning decoction on asthma induced by RSV[J].New traditional Chinese medicine, 2007,39(4):16-17.
(17)Zhu Y,Wang M Q,Luo Y H,Chen X J,Liu K L,Mo F J,Shu L.The clinical study and the analysis of related factors of the treatment of Kechuanning decoction on asthma induced by RSV[J].Chinese Journal of information on traditional Chinese Medicine.2007,14(2):63-64.
(18)Wang M Q,Luo Y H,Chen X J.Zhu Y.Liu K L,Mo F J.Shu L.The regulation on subgroup Th by Kechuanning decoction on asthma induced by RSV[J].Chinese Journal of traditional Chinese Medicine,2007,22(7):481-483.
[19]Dong X F,Luo Y H,Wang M Q,Chen X J, Zhu Y.The regulation of EOS on asthmatic guinea pig by Kechuanning decoction[J]. Journal of Hunan University of traditional Chinese Medicine, 2008,28(5):36-37,60
[1]Teichtahl H.Buckmaster N.Pertnikovs E.The incidence of respiratory tract infection in adults requiring hospitalization for asthma. Chest,1997.112:591-596.
[2]Zheng J S,Zhu C.Su M S,Li C C,Jin X H,Chen X F.The etiological analysis of respiratory tract viral when acute asthma attacked of the following children under 5 years old[J]Journal of Wenzhou Medical College,2005,35(6):483-484.
[3]Cui FF.Xin D L. Animal model of bronchial asthma[J]. Laboratory animal and comparative medicine.2009.29(4):277-281
[4]Xiao C J.Research on the mechanism of clearing the lung and antiasthmatic method and syndrome differentiation of Pediatric Heat-asthma microcosmic.[J]Doctoral Dissertation of Hunan University of Chinese Medicine.2001,25-38.
[5]Liu L N.Yang J G,Cheng D Q.Buiding of asthma mice model induced by Respiratory syncytial virus [J] Journal of Zhejiang University of traditional Chinese Medicine.2007.31(2):154-155.157.
[6]Jiang H L,Li Y P.Zhou T Y. changes of T lymphocyte subsets in airway of Asthma mice [J].The Journal of Practical Medicine,1999,15(7):585-586.
[7]Ji L L.Xu L,Shi L,Feng L. The research of the evaluation and the observation on asthma animal model [J]. Chinese Journal of Comparative Medicine.2009,19(1):72-75.
[8]徐立,范欣生,何胜旭.复方辛夷口服液对卵蛋白致敏豚鼠支气管哮喘的影响[J]南京中医药大学学报.2004,20(2)：104-106.
[9]蒋雄斌,朱毅,殷凯生.重度哮喘小鼠模型的建立[J]中国危重病急救医学.2006.18(12)：733-737.
[10]徐叔云.卞如濂,陈修.药理实验方法学(第2版)[M].北京：人民卫生出版社,1991：1171-1195.
[11]Katsunori K.Bosken CH, Pare PD.et al. Small airways dimensions in asthma and chronic obstructive pulmonary disease [J].Am Rev Respir Dis,1993,148:1220-1225.
[12]董泽华,魏剑琴,黄瑾,等.哮喘豚鼠模型痉挛气道的解痉挛规律[J]吉林大学学报.2006,32(4)：562-563.
[13]毕玉田，王彦,吴奎等.屋尘螨致敏激发小鼠气道变态反应性炎症模型的构建[J].中国实验动物学报，2007,15(5)：338-340.
[14]胡作为,周电光,周燕萍,等.中药止哮平喘方抗哮喘豚鼠模型气道炎症的实验研究[J].广州中医药大学学报.2004,21(1)：40-42.
[15]赖克方,王长征,郭先健,等.支气管哮喘豚鼠肺内嗜酸粒细胞增多和凋亡的关系[J].广东医学.2001,22[2]98-99.
[16]陈奇.中药药理研究方法学(第2版)[M].北京：人民卫生出版社,2006：642-643.
[17]张全爱.哮喘模型豚鼠变态反应机制的实验研究[J].甘肃中医学院,2003.20(4)：16-17.
[18]陈莹,戴晋.多种细胞因子在哮喘大鼠发病中的作用[J].中国组纽织工程研究与临床康复.2007,11(27)：5324-5327.
[19]Matthiesen S. Bahulayan A, Holz O,et al.MAPK pathway mediates muscarinic receptor-induced human lung fibroblast proliferation[J]Life Sci.2007(24-25):2259-2262.
[20]Liu S Z.LiuY L.Cao G L, et al.The points of immune inflammation verification in Animal models of asthma [J] Chinese Journal of clinical rehabilitation,2007,11(22):5814-5816.
[21]Chin J. Magoffin RL, Shearer LA, et al. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol 1969:89 (4):449-463.
[22]张惠兰.张珍祥,徐永健,等.用紫外线灭活的呼吸道合胞病毒复制小鼠哮喘动物模型.中国病理生理杂志.2002.18：1561-1563.
[23]沈华浩.三苹莉.支气管哮喘小鼠模型应用评价.中华结核和呼吸杂志.2005：28：284-286.
[24]Makela MJ. Tripp R. Dakhama A, et al. Prior aiway exposure to allergen increases virus-inudced airway hyperresponsiveness. J Allegry Clin Immunol,2003.112:61-69.
[1]Dou L Y.Virus infection and exacerbation of acute asthma.Medical Journal of Western China.2007; 22(1):193-194.
[2]BARNES P J.ADCOCK I M.Transcription factors and asthma[J].Eur Respir J,1998.12(1):221-234.
[3]LICC,YEL,CHEN X F. et al.Expression of signal transducer and activator of transcription 6 in rat asthma model and the modulatory effect of dexamethasone[J].Chin J Pediatr(中华儿科杂志),2005,43(7):521-525.
[4]Chinese Medical Association of pediatric subspecialty group of respiratory.The routine of prevention and treatment of bronchial asthma of children (on trial)[J].Chinese Journal of Pediatrics,2004,42:100-106.
[5]Barnes PJ, Adeock IM. Transcription factors and asthma [J].EUr Respir J.1998,12:221-234.
[6]Huang W L.Zhu X F. Signal transduction.BeiJing:People hygiene press,2005.
[7]Kaphlan MH.Nyce JW,Metager WJ,et al.DNA antisense therapy for asthma in an animal model.[J]Immunol Baltimore,1998,160(4):1850-1856.
[8]Wang M Q,Luo Y H,Chen X J.Zhu Y,Liu K L.Mo F J,Shu L.The regulation on Th subgroup by Kechuanning decoction on asthma induced by RSV[J].Chinese Journal of traditional Chinese Medicine, 2007,22(7):481-483.
[9]Kuo CT Leiden JM.Transcriptional regulation of T lymphocyte development and function.[J].Annu Rev Imnunol,1999.17:149-187.
[10]Steinke JW, Borish L. Th2 cytokines and asthma.Interleukin-4:its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists[J].Respir Res.2001;2(2):66-70. Epub 2001 Feb 19.
[11]Gately MK.Renzetti LM.Magram J.et al.The IL-12/IL-12R system:role in normal and pathologic immune responses.[J].Annu Rev Immunol.1998.16:495-521.
[12]Teichtahl H.Buckmaster N.Pertnikovs E.The incidence of respiratory tract infection in adults requiring hospitalization for asthma[J].Chest,1997.112:591,496.
[13]Ye L P,Xie L W,Li C C,Wu S Z.Li M R.The expression of signal transducer and activator of transcription 6 in asthmatic rats by Budesonide[J]Chinese Journal of Microbiology andImmunology,2005,25(7):588-593.
[14]Kaplan MH.Grusby M J.Regulation of T helper cell differentiation by STAT molecules[J].Leukoc Biol,1998,64:2-5.
[15]Wang M Q.Luo Y H.Chen X J,Zhu Y.Liu K L,Mo F J,Shu L.The clinical study of the treatment of Kechuanning decoction on asthma induced by RSV[J].New traditional Chinese medicine,2007,39(4):16-17.
[16]Zhu Y.Wang M Q,Luo Y H,Chen X J.Liu K L.Mo F J,Shu L.The clinical study and the analysis of related factors of the treatment of Kechuanning decoction on asthma induced by RSV[J].Chinese Journal of information on traditional Chinese Medicine,2007,14(2):63-64.
[17]Wang M Q,Luo Y H,Chen X J,Zhu Y,Liu K L.Mo F J.Shu L.The regulation on Th subgroup by Kechuanning decoction on asthma induced by RSV.[J].Chinese Journal of traditional Chinese Medicine.2007,22(7):481-483.
[18]Dong X F.Luo Y H,Wang M Q,Chen X J,Zhu Y,The regulation of EOS on asthmatic guinea pig by Kechuanning decoction[J].Journal of Hunan University of traditional Chinese Medicine,2008,28(5):36-37,60
[1]Cho SH.Stanciu LA,Begishivili T,Bates PJ.Holgate ST, Johnston SL.Peripheral blood CD4- and CD8 T cell type 1 and type 2 cytokine production in atopic asthmatic and normal subjects[J].Clin Exp Allergy. 2002.32(3):427-33.
[2]Miyahara N.Takeda K.Kodama T,Joetham A.Taube C.Park JW.Miyahara S.Balhorn A,Dakhama A.Gelfand EW.Contribution of antigen primed CD8+ T cells to the development of airway hyperresponsiveness and inflammation is associated with IL-13[J].Immunol.2004.172(4):2549-58.
[3]Niedbala W,Wei X.Liew FY. IL-15 induces type 1 and type 2 CD4+ and CD8- T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12/IL-4 stimulation in vitro[J].Eur J Immunol,2002,32(2):341-7.
[4]Cherwinski HM,Schumacher JH.Brown KD et al.Two types of mouse helper T cell clone.III.Further differences in lymphokine synthesis between Thl and Th2 clones revealed by RNA hybridization functionally monospecific bioassays.and monoclonal antibodies[J].Exp Med.1987;166:1229-1244
[5]Ransom J,Fischer M.Mosmann T.et al.Interferon-gammal is produced by activated immature mouse thymocytes and inhibits the interleukin 4-induced proliferation of immature thymocytes[J]. Immunol,1987:139:4102-4.108
[6]Fiorentino DF.Bond MW.Mosmann TR.Two types of moues T helper cell. IV Th2 clones secrete a factor that inhibits cytokine production by Thl clones[J].Exp Med.1989:170:2081-2095
[7]Fernandez-Botran R.Sanders VM.Mosmann TR et al.Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells[J].Exp Med 1988; 168:543-558
[8]Sher A.Gazzinelli RT.Oswald IP,et al. Role of T-Cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection[J].Immunol Rev.1992; 127:183-204
[9]Katsunuma T,Kawa hara H.Suda T,Ishii T,Ohya Y,Akasawa A,Saito H,Oshida T,Sugita Y.Analysis of gene expressions of T cells from children with acute exacerbations of asthma[J].Int Arch Allergy Immunol.2004,134(1):29-33.
[10]Noma T,Sugawara Y.Aoki K.Kawa no Y,Ishikawa Y,Matsuura N.Induction of peripheral mononuclear cell apoptosis in asthmatic patients in remission[J].Asthma.2002.39(7):591-601.
[11]Bach FH.Delayed xenograft rejection[J].Immunology Today,1996,11:63-67.
[12]MosmannTR.Cytokines:is there biological meaning?[J].Curr OPin Immunol.1991 Jun;3(3):311-4.
[13]Shiota Y, Arikita H, Horita N, Hiyama J, Ono T, Yamakido M. Intracellular IL-5 and T-lymphocyte subsets in atopic and nonatopic bronchial asthma[J].Allergy Clin Immunol.2002.109(2):294-8.
[14]Cho SH,Stanciu LA.Holgate ST,Johnston SL.Increased interleukin-4,interleukin-5 and interferon-gamma in airway CD4-and CD8+T cells in atopic asthma.Am J Respir Crit Care Med.2005.171(3):224-30.
[15]Shi HZ,Sun JJ,Pan HL,LuJQ,Zhang JL,Jiang JD.Alternations of T-lymphocyte subsets,soluble IL-2 receptor.and IgE in peripheral blood of children with acute asthma attacks[J].Allergy Clin Immunol.1999.103(3pt1):388-394.
[16]Shi JH,Li TS.Lin YG.The evolvement of Thl/Th2 imbalance accommodates to the progress of airway inflammation in asthmatic subjects and rat model[J].Chinese Medical Journal.2004.84(17):1440-4.
[17]Lee SY,Kim SJ,Kwon SS,Kim YK.Kim KH.Moon HS.Song JS,Park SH. Distribution and cytokine production of CD4 and CD8'T-lymphocyte subsets in patients with acute asthma attacks[J].Ann Allergy Asthma Immunol.2001.86(6):659-64.
[18]Kelly-welch AE,Hanson EM,Boothby MR.Keegan AD.Interleukin-4 and Interleukin-13 signaling connections Maps[J].Science.2003.300(5625):1527-1528.
[19]Schedel M.Carr D.Klopp N.Woitsch B,l Ilig T,Stachel D.Schmid I.Fritzsch C.Weiland SK.Von Mutius E.Kabesch M.A signal transducer and activator of transcription 6 haplotype influences the regulation of serum IgE levels[J].Allergy Clin Immunol.2004.114(5):1100-5.
[20]Ammit AJ.Panettieri RA Jr.Invited review the circle of life:cell cycle regulation in airway smooth muscle[J].App] physiol.2001,91 (3):1431-7.
[21]Shi H Z,Lin J T.Immunology of lung and immune related diseases[M].BeiJing:People hygiene press,2006:316-317.
[22]Sheng Q,He J Y,Zhou A L,et al.The expression of signal transducer and activator of transcription 6 and Eotaxin by Triptolide on asthmatic mice[J].International Journal of Cardiology,2006,26(1):12-15.
[23]Wang M Q,Luo Y H.Chen X J.Zhu Y,Liu K L,Mo F J,Shu L.The regulation on subgroup Th by Kechuanning decoction on asthma induced by RSV[J].Chinese Journal of traditional Chinese Medicine,2007,22(7):481-483.
[24]Dong X F.Luo Y H.Wang M Q,Chen X J.Zhu Y.The regulation of EOS on asthmatic guinea pig by Kechuanning decoction[J].Journal of Hunan University of traditional Chinese Medicine.2008.28(5):36-37,60.
[1]汪受传主编.中医儿科学[M].北京：中国中医药出版社,2002.75
[2]郭云霞.儿童哮喘证治的中医药研究摘要[J].中医药学刊，2002,20(2)：201
[3]洪广祥.哮证治疗之我见[J].中医杂志,1998，29(3)：7
[4]王根军.从风痰论治急性发作期支气管哮喘[J].中华实用中西医杂志,2005,18(13)：233
[5]沈自尹.补肾法预防哮喘的变态和非变态反应机制研究[J].中西医结合杂志,1989，9(2)：82
[6]史锁芳.哮喘“夙根”探讨[J].中医药学报,1994,(3)：6
[7]韦衮政.敖素华.胡天成治疗小儿哮喘经验举隅[J].辽宁中医杂志.2002.29(10)：585
[8]彭红星.陈陶后教授治疗小儿哮喘经验[J].山西中医,1995,(2)：5
[9]张伟.邵雨萌.再论哮喘从瘀论治[J].湖南中医学院学报.2004.24(3)：24
[10]朱鹏.复元活血汤治疗哮喘12例疗效观察[J].江西中医药,1995,(5)：33
[11]廖世才.小儿哮喘活血化瘀法治疗体会[J].江西中医药.1997,28(6)：33
[12]洪霞,廖宝军.从痰瘀论治小儿哮喘116例分析.陕西中医函授.2000.(5)：41
[13]周仲瑛.哮喘杂谈.江苏中医.2000.21(18)：15
[14]洪广祥.哮证治疗之我见[J].中医杂志.1988,29(3)：7
[15]胡国俊.胡翘武治疗支气管哮喘的经验[J].中国医药学报.1993.8(5)：56
[16]张建明.哮喘有因血虚论[J].中医杂志.1992,33(9)：57
[17]沈俊元.中西医结合治疗小儿支气管哮喘36例[J].中国中西医结合杂志，1995,15(12)：754
[18]高淑英.哮喘从肝肺论治探讨[J].中国中医药信息杂志,2006,13(8)：77
[19]武维屏,崔红生.试论支气管哮喘从肝论治的生理病理学基础[J].中国中医基础医学杂志,2002,8(10)：7-8
[20]毛玉燕.钱育寿.治疗小儿哮喘的经验.河北中医，2000.22(3)：174
[21]王青海,黄琳.等.胃不和与支气管哮喘的关系初探[J].广东医学,2001,22(8)：755
[22]许建中.吴银根,李明华.中西医结合哮喘病学[M1.北京：人民卫生出版社.2001,7
[23]刘小凡,司东波.小儿哮喘间歇期的证治探讨[J].中国中医急症,2004,13(5)：29
[24]罗玉华.小儿哮喘的中医辨证治疗.四川中医.2002,20(1)：17
[25]曹宏,陈鲁.补肾培元法治疗小儿哮喘体会[J].陕西中医，2000.21(8)：3
[26]范钰,万救钢,万铭.等.黄芪注射液对哮喘患者气道反应性的影响[J].新中医,2001，33(4)：27
[27]王孟清.朱哗,舒兰,等.截哮口服液防治病毒诱发小儿哮喘的临床研究[J].中国中西医结合杂志,2003.23(12)：902-904
[28]周志荣.复方太子参止咳益气散治疗支气管哮喘2180例疗效观察.中国民族医药杂志,2005(5)：12
[29]杨明升.儿康宁佐治婴幼儿哮喘缓解期疗效观察[J].实用中西医结合杂志,1995,11(1)：52
[30]贺双腾.等.五虎汤对呼吸道卫国合胞病毒复制的抑制作用研究.[J]中草药.1995,26(11)：585.
[31]阎玉田，等.中西医结合治疗合胞病毒肺炎的临床,病理及发病机制研究.[J]中国中西医结合急救杂志.1999,6(11)：489.
[32]廖传胜，等.柴胡注射液抑制RSV的研究.[J]深圳中西医杂志.1999,9(2)：20.
[33]董艳梅,等.甘草体外抑制呼吸道合胞病毒作用的研究.[J]中药材.2004,27(6)：425-427.
[34]余栋华.鱼腥草注射液治疗小儿合胞病毒性肺炎41例.现代中西医结合杂志.1999,8(2)：1957.
[35]樊宏伟,等.苦参碱类生物碱的体外抑菌,抑病毒及诱生干扰素的实验研究.[J]中医药信息.2000,(4)：75.
[36]杨桦.人参多糖抗RSV感染的作用机制研究.[J]中国药理学通报.1997,13(4)：382.
[1]全国儿科哮喘协作组.2000年与1990年儿童支气管哮喘患病率的调查比较.中华结核和呼吸杂志，2004，27(2)：112-115.
[2]Openshaw PJ,YamaguchiY,Tregoning JS.Childhood infections,the developing immune system.and the origins of asthma[J]. Allergy Clin Immunol.2004.114(6):1275-1277.
[3]郑吉善，朱春.苏苗赏.李昌崇.金小红.陈小芳.5岁以下儿童哮喘急性发作时呼吸道病毒病原学检测分析.[J].温州医学院学报.2005.35(6)：483-484.
[4]窦丽阳.病毒感染与哮喘的急性加重.华西医学2007；22(1)：193-194.
[5]The global initiative for asthma. Global strategy for asthma management and prevention:mechanisms of asthma [M].New York:National institutes of health,2002:50-54.
[6]Kim CK,Kim SW,Park CS,etal. Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis[J].Allergy Clin Immunol.2003,112(1):64
[7]Brooks GD,Buchta KA..Swenson CA,et al.Rhingovirus-indueced interferon-γand airway responsiveness in asthma[J].Am J Respir Crit Care Med,2003,168(9):1091.
[8]Papadopoulos NG,Stanciu LA,Papi A.et al.A defective typelresponse to rhinovirus in atopic asthma[J].Thorax,2002,579(4):328.
[9]Legg JP,Hussain IR,Warner JA,et al. Typeland type2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis[J].Am J Respir Crit Care Med,2003,168(6):633
[10]Zambrano JC.Carper HT,Rakes GP,et al. Experimental rhinovirus challenges in adults with mild asthma: response to infection in relation to IgE[J].J Allergy Clin lmmunol,2003,111 (5):1008
[11]Yamaya M, Sasaki H. Rhinovirus and asthma [J].Viral Immunol.2003.16(2):99
[12]McNamara PS, Flanagan BF, Baldwin LM, et al. Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis [J].Lancet.2004,363(9414):1031
[13]Park JW, Taube C,Yang ES,et al. Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen[J].Allergy Clin Immunol,2003,112(6):1078
[14]Kong X, San Juan H, Kumar M,et al. Respiratory syncytial virus infection activates STAT signaling in human epithelial cells[J].Biochem Biophys Res Commun,2003,306(2):616
[15]Samransamruajkit R, Moonviriyakit K, Vanapongtipagorn P,et al. Plasma endothelin-1in infants and young children with acute bronchiolitis and viral pneumonia[J].Asian Pac J Allergy Immunol,2002.20(4):229
[16]Chauhan AJ. Inskip HM Linaker CH, et al. Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children[J]. Lancet,2003.361(9373):1939
[17]Oh JW, Lee HB, Park IK,et al.Interleukin-6. interleukin-8. interleukin-11, and interferon-gamma levels in nasopharyngeal aspirates from wheezing children with respiratory syncytial virus or influenza A virus infection[J].Pediatr Allergy Immunol.2002.13(5):350.
[18]薛辛东,李永柏.儿科学[M]北京：人民卫生出版社.2002.229-241.
[19]Empey DW, Laitinen LA.Jacobs L.et al.Mecanisms of bronchial hyperreactivity in normal subjects following upper respiratory tract infection[J].Amm Rev Respir Dis.1976,113(2):523.
[20]Folkerts G,Vanderlinde HJ,Nijkamp FP.Virus indueced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide[J].Clin Invest. 1995.95(1 ):26
[21]Fryer AD,Maclagan J.Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig[J].Br J Pharmacol, 1984.83(4):973
[22]Jacoby DB,Xiao HQ,Lee NH.et al.Virus and interferon induced los of inhibitory M2 muscarinic receptor function and gene expression in guinea-pig airway parasympathetic neurons[J].Clin Invest.1998, 102(1):242
[23]Costello RW, Schofield BH, Kephart GM, et al.Lolization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function[J].Am J Physiol. 1997.273( 1 ):93
[24]Adamko DJ. Fryer AD. Bochner BS,et al. CD8+ T lymphocytes in viral hyperreactivity and M2 muscarinic receptor dysfunction[J]. Am J Respir Crit Care Med. 2003.167(4):550
[25]鹿强.杨卫,杨永丰.支气管哮喘的气道重塑.[J]河北医药.2010.32(10)：1299-1301.
[26]Wilsion JW. Lack of airway distensibHty in asthma. AM. Rev, Respir. Dis.1993,148:806-809.
[27]Kraft M.Martin RJ.Wilson S,et al.Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med, 1999,159:228-234.
[28]Srivastava P. Helms PJ, Stewart D.et al. Association of CCR5D et al .32 with reduced risk of childhood but not adult asthma[J].Mol Biotechnol.2003.23(l):51-60.
[29]Yao TC, Kuo ML,See LC,et al. The RANTES promoter polymor-phism:a genetic risk factor for near-fatal asthma in Chinese children[J].Thorax.2003.58(6):466-469.
[30]Van EP,Little RD,Dipuis J,et al. Association of the ADAM-33 gene with asthma and bronchial hyperresponsiveness [J].Nature, 2002.418:426-430.
[31]Urban JF et al.J Immunol Baltimore, 2000, 164(4):2046-2052 .
[32]Kplan MH et al.J Immunol Baltimore. 1998. 160(4): 1850-1856.
[33]Stamm LM et al.J Immunol Baltimore, 1998. 161(11):6180-6188.
[34]Guell FW et al. Mol Cell Biol,1995. 15(6):3336-3343.
[35]Yokozeki H et al.J Exp Med.2000.191(7):995-l()04.
[1]蒋雄兵.朱毅，殷凯生,等.CD8mAb对呼吸道合胞病毒诱导的哮喘小鼠气道炎症的影响[J].第四军医大学学报.2006,27(12)：1086-1089.
[2]王孟清,罗银河.陈锡军.朱晔,刘克丽.莫非钧，舒兰.咳喘宁治疗病毒诱发的儿童哮喘的临床研究[J].新中医，2007.39(4)：16-]7.
[3]王孟清,罗银河,陈锡军,朱晔,刘克丽，莫非钧.舒兰.咳喘宁对病毒诱发哮喘患儿Th亚群的调节作用[J].中华中医药杂志,2007,22(7)：481-483.
[4]董晓斐,罗银河.王孟清.陈锡军.朱晔.咳喘宁对哮喘豚鼠EOS的调节作用[J].湖南中医药大学学报.2008.28(5)：36-37.
[5]杨季国,徐朝晖,等.平喘Ⅰ号对呼吸道合胞体病毒哮喘小鼠血清IL-4.IFN-γ的影响[J].中国中医药科技,2008.15(1)：26-27.
[6]蔡宛如,等.芍药甘草汤平喘和抗过敏的实验研究[J].中国中西医结合急救杂志.2000.11(6)：341-342.
[7]王力宁.等.六味地黄丸协同必可酮对致敏豚鼠气道反应性和血嗜酸细胸的影响[J].广西中医药.2000,2(6)：52-53.
[8]张建勇.火把花根片对哮喘豚鼠气道炎症的作用[J].贵州医药,2001，11(10)：89-92.
[9]薛汉荣,等.益气温阳护卫汤对缓解期哮喘患者气道反应性的影响及作用机理研究[J].中国医药学报.2004,19(8)：477.
[10]李彤.平哮合剂对哮喘气道高反应性的影响[J].山西中医.2001,17(3)：44.
[11]Fish JE,Peters SP.Airway remodeling and persistent airway obstruction in asthma[J].Allergy clin Immunol,1999,104 (3Pt1):509.
[12]吴银根,王丽新.基质金属蛋白酶及其抑制剂在哮喘气道重塑中的作用及止喘胶囊的干预[J].中西医结合学报,2004,2(6)：435.
[13]汪珊,梁仁.中药地龙药理与哮喘气道重建相关性研究[J].广东药学院学报,2004,20(1)：60.
[14]Hogansp,KoskinerA,MatthaeiK1,et al.Interleukin-5 producing CD4+T cell spalyapivotal roleinaero allegen-induced eosinophilia,bronchial hyperreactivity and lung damage immune Am[J].Respir Crit Care Med 1998,157(1):210-218.
[15]Mudle R,Chancz P,Campbell AM,et al.Different eytokine paterns in bronchial bisopsies in asthma and chronic bronchitis[J].respir Med,1996,90(2):79.
[16]张在其,梁仁,黄建明.小青龙汤对哮喘小鼠肺组织Thl/Th2作用的实验研究[J].中国中西医结合急救杂志,2004,(6)：368-370.
[17]张莉,孙建宁,周勇.等.芩夏止哮颗粒对豚鼠支气管平滑肌的影响及平喘作用[J].北京中医药大学学报.1999,11(6)：42-44.
[18]壮健,孙秀芳.徐教萍，等.消喘膏贴敷对哮喘豚鼠Thl/Th2类细胞因子的影响[J].四川中医.2003,1(6)：13.
[19]罗光伟，孙浩民，陈菁.射干麻黄汤对哮喘豚鼠气道ECP和嗜酸性粒细胞凋亡的影响[J].中国中医急症,2006,15(6)：639-640.
[20]方向明.曹世宏.平喘合剂对哮喘豚鼠T淋巴细胞凋亡的影响[.11.中国中医基础医学杂志,2003,9(3)：]84-186.
[21]王宏长.李培成，吴银根.中药咳喘落对实验性哮喘豚鼠ECP和sICAM-1的影响[J].广东医学,2000.21(3)：]88-190.
[22]李刚,柳春，李莉,等,复方抗敏灵对哮喘大鼠ICAM-1表达及PL A2的影响[J].微生物学杂志,2000,20(2)：39.
[23]魏庆宇，李刚.柳春.加味玉屏风散对哮喘大鼠支气管上皮ICAM-1的表达及BALF中IL-5含量的影响[J].中国实验方剂学杂志.2001.(5)：40-42.
[24]郑洁湖国信,邱忠民.蠲哮片对哮喘豚鼠sICAM-1蛋白水平及ICAM-1基因表达的影响[J].江西中医学院学报.2003,15(4)：42-44.
[25]林科雄,雷公藤对哮喘豚鼠GM-CSF基因转录的影响与作用机制[J].中国免疫学杂志,2000,(9）：325-327.
[26]李志奎,等.雷公藤甲素对哮喘豚鼠嗜酸性粒细胞凋亡及Fas、Bcl、MRNA表达的影响[J].中国新药与临床杂志,2002,5(5)：261-262.
[27]王宏长,等.中药哮喘落对哮喘大鼠肺组织白细胞介素-4、IL-5mRNA影响及相关性研究[J].广东医学.2000,21(2)：107.
[28]范欣生,等.复方辛夷平喘液对哮喘豚鼠肺内ICA及淋巴细胞fas表达的影响[J].中华结核和呼吸杂志,2002,25(5)：280.
[29]刘永刚,罗佳波.麻黄汤及拆方对哮喘小鼠5.脂质氧合酶激活蛋白、白介素4基因的表达和影响[J].中国中药杂志,2007.32(3)：246-248.
[30]方向明,王军.平喘宁对哮喘豚鼠肺组织中GM-CSF mRNA表达的影响[J].中华中医药杂志.2005.20(9)：538-541.
[31]张毅敏.穴位敷贴对哮喘豚鼠嗜酸性粒细胞凋亡及其调控基因的影响[J].北京中医药大学学报,2006,29(6)：393-395.